Enrichment of regulatory CD4+CD25+ T cells by inhibition of phospholipase D signaling

Nature Methods

Volumn 3, Issue 8, 2006, Pages 629-636

  Singh, Nagendra ^a   Seki, Yoichi ^a   Takami, Mariko ^a   Baban, Babak ^a   Chandler, Phil R ^a   Khosravi, Davood ^a   Zheng, Xiangjian ^a   Takezaki, Mayuko ^a   Lee, Jeffrey R ^a,b   Mellor, Andrew L ^a   Bollag, Wendy B ^a   Iwashima, Makio ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPASE D; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION;

EID: 33746398120     PISSN: 15487091     EISSN: 15487105     Source Type: Journal    
DOI: 10.1038/nmeth903     Document Type: Article

References (30)

1. Melendez, A.J. & Allen, J.M. Phospholipase D and immune receptor signaling. Semin. Immunol. 14, 49-55 (2002).
2. Exton, J.H. Phospholipase D structure, regulation and function. Rev. Physiol. Biochem. Pharmacol. 144, 1-94 (2002).
3. Andresen, B.T., Rizzo, M.A., Shome, K. & Romero, G. The role of phosphatidic acid in the regulation of the Ras/MEK/Erk signaling cascade. FEBS Lett. 531, 65-68 (2002).
4. Yang, C. & Kazanietz, M.G. Divergence and complexities in DAG signaling: looking beyond PKC. Trends Pharmacol. Sci. 24, 602-608 (2003).
5. Liu, G.L., Shaw, L., Heagerty, A.M., Ohanian, V. & Ohanian, J. Endothelin-1 stimulates hydrolysis of phosphatidylcholine by phospholipases C and D in intact rat mesenteric arteries. J. Vasc. Res. 36, 35-46 (1999).
6. Frohman, M.A., Sung, T.C. & Morris, A.J. Mammalian phospholipase D structure and regulation. Biochim. Biophys. Acta 1439, 175-186 (1999).
7. McDermott, M., Wakelem, M.J. & Morris, A.J. Phospholipase D. Biochem. Cell Biol. 82, 225-253 (2004).
8. Colley, W.C. et al. Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr. Biol. 7, 191-201 (1997).
9. Sung, T.C. et al. Mutagenesis of phospholipase D defines a superfamily including a trans-Golgi viral protein required for poxvirus pathogenicity. EMBO J. 16, 4519-4530 (1997).
10. Sugars, J.M., Cellek, S., Manifava, M., Coadwell, J. & Ktistakis, N.T. Fatty acylation of phospholipase D1 on cysteine residues 240 and 241 determines localization on intracellular membranes. J. Biol. Chem. 274, 30023-30027 (1999).
11. Xie, Z., Ho, W.T. & Exton, J.H. Requirements and effects of palmitoylation of rat PLD1. J. Biol. Chem. 276, 9383-9391 (2001).
12. Czarny, M. et al. Phospholipase D2: Functional interaction with caveolin in low-density membrane microdomains. FEBS Lett. 467, 326-332 (2000).
13. Morris, A.J., Frohman, M.A. & Engebrecht, J. Measurement of phospholipase D activity. Anal. Biochem. 252, 1-9 (1997).
14. Biffen, M., Shiroo, M. & Alexander, D.R. Selective coupling of the T cell antigen receptor to phosphoinositide-derived diacylglycerol production in HPB-ALL T cells correlates with CD45-regulated p59fyn activity. Eur. J. Immunol. 23, 2980-2987 (1993).
15. Mollinedo, F., Gajate, C. & Flores, I. Involvement of phospholipase D in the activation of transcription factor AP-1 in human T lymphoid Jurkat cells. J. Immunol. 153, 2457-2469 (1994).
16. Reid, P.A., Gardner, S.D., Williams, D.M. & Harnett, M.M. The antigen receptors on mature and immature T lymphocytes are coupled to phosphatidylcholine-specific phospholipase D activation. Immunology 90, 250-256 (1997).
17. Sakaguchi, S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6, 345-352 (2005).
18. Tijsterman, M. & Plasterk, R.H. Dicers at RISC; the mechanism of RNAi. Cell 117, 1-3 (2004).
19. Fontenot, J.D. & Rudensky, A.Y. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol. 6, 331-337 (2005).
20. Singh, B. et al. Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182, 190-200 (2001).
21. Ochs, H.D., Ziegler, S.F. & Torgerson, T.R. FOXP3 acts as a rheostat of the immune response. Immunol. Rev. 203, 156-164 (2005).
22. Mellor, A.L. et al. Cutting edge: Induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J. Immunol. 171, 1652-1655 (2003).
23. Taniguchi, T. & Minami, Y. The IL-2/IL-2 receptor system: A current overview. Cell 73, 5-8 (1993).
24. Yamasaki, S., Takamatsu, M. & Iwashima, M. The kinase, SH3, and SH2 domains of Lck play critical roles in T-cell activation after ZAP-70 membrane localization. Mol. Cell. Biol. 16, 7151-7160 (1996).
25. Gavin, M.A., Clarke, S.R., Negrou, E., Gallegos, A. & Rudensky, A. Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat. Immunol. 3, 33-41 (2002).
26. Tang, Q. et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199, 1455-1465 (2004).
27. + regulatory T cell subsets. J. Leukoc. Biol. 74, 471-478 (2003).
28. Mage, M.G. In vitro assays for mouse lymphocyte function. In Current Protocols in Immunology (eds., Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M. & Strober, S.) 3.5.1-3.5.6 (John Wiley & Sons, Indianapolis, 1993).
29. Iwashima, M. et al. Genetic evidence for Shc requirement in TCR-induced c-Rel nuclear translocation and IL-2 expression. Proc. Natl. Acad. Sci. USA 99, 4544-4549 (2002).
30. Zheng, X., Ray, S. & Bollag, W.B. Modulation of phospholipase D-mediated phosphatidylglycerol formation by differentiating agents in primary mouse epidermal keratinocytes. Biochim. Biophys. Acta 1643, 25-36 (2003).